Insider · CIK 0001629472

Viking Global Opportunities Portfolio GP LLC

CIK 0001629472 Name as filed on the most recent filing

Filed as Viking Global Opportunities Portfolio GP LLC (44)

106 transaction lines · from 44 filings · filed 2016-02-08 to 2025-10-09 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2020-11-11 S, Open-market sale Adaptive Biotechnologies CorpADPT 123,787,500, disposed Open Form 4 filing 0001387131-20-009937
2020-08-26 P, Open-market purchase Inhibrx, Inc.INBX 2 lines 3,409,866, acquired Open Form 4 filing 0001387131-20-008019
2020-08-25 P, Open-market purchase Inhibrx, Inc.INBX 2 lines 1,651,687, acquired Open Form 4 filing 0001387131-20-007889
2020-08-24 P, Open-market purchase Inhibrx, Inc.INBX 897,001, acquired Open Form 4 filing 0001387131-20-007889
2020-04-07 P, Open-market purchase Zentalis Pharmaceuticals, Inc.ZNTL 13,050,000, acquired Open Form 4 filing 0001387131-20-003800
2020-01-28 S, Open-market sale Adaptive Biotechnologies CorpADPT 122,706,039, disposed Open Form 4 filing 0000903423-20-000010
2019-07-01 P, Open-market purchase Adaptive Biotechnologies CorpADPT 5,000,000, acquired Open Form 4 filing 0000903423-19-000272
2019-06-27 P, Open-market purchase BridgeBio Pharma, Inc.BBIO 80,000,300, acquired Open Form 4 filing 0000903423-19-000265
2019-06-19 P, Open-market purchase Urovant Sciences Ltd.UROV 40,495, acquired Open Form 4 filing 0000903423-19-000252
2019-06-18 P, Open-market purchase Urovant Sciences Ltd.UROV 55,061, acquired Open Form 4 filing 0000903423-19-000252
2019-06-17 P, Open-market purchase Urovant Sciences Ltd.UROV 55,825, acquired Open Form 4 filing 0000903423-19-000252
2019-06-14 P, Open-market purchase Urovant Sciences Ltd.UROV 56,514, acquired Open Form 4 filing 0000903423-19-000247
2019-06-13 P, Open-market purchase Urovant Sciences Ltd.UROV 58,543, acquired Open Form 4 filing 0000903423-19-000247
2019-06-12 P, Open-market purchase Urovant Sciences Ltd.UROV 62,244, acquired Open Form 4 filing 0000903423-19-000247
2019-06-11 P, Open-market purchase Urovant Sciences Ltd.UROV 61,694, acquired Open Form 4 filing 0000903423-19-000242
2019-06-10 P, Open-market purchase Urovant Sciences Ltd.UROV 62,594, acquired Open Form 4 filing 0000903423-19-000242
2019-06-07 P, Open-market purchase Urovant Sciences Ltd.UROV 52,959, acquired Open Form 4 filing 0000903423-19-000242
2019-06-06 P, Open-market purchase Urovant Sciences Ltd.UROV 56,621, acquired Open Form 4 filing 0000903423-19-000240
2019-06-05 P, Open-market purchase Urovant Sciences Ltd.UROV 52,418, acquired Open Form 4 filing 0000903423-19-000240
2019-06-04 P, Open-market purchase Urovant Sciences Ltd.UROV 56,911, acquired Open Form 4 filing 0000903423-19-000240
2019-06-04 P, Open-market purchase Myovant Sciences Ltd.MYOV 19,999,997, acquired Open Form 4 filing 0000903423-19-000245
2019-06-03 P, Open-market purchase Urovant Sciences Ltd.UROV 41,815, acquired Open Form 4 filing 0000903423-19-000236
2019-05-31 P, Open-market purchase Urovant Sciences Ltd.UROV 39,042, acquired Open Form 4 filing 0000903423-19-000236
2019-05-30 P, Open-market purchase Urovant Sciences Ltd.UROV 2 lines 58,090, acquired Open Form 4 filing 0000903423-19-000236
2019-05-29 P, Open-market purchase Urovant Sciences Ltd.UROV 51,983, acquired Open Form 4 filing 0000903423-19-000232
2019-05-28 P, Open-market purchase Urovant Sciences Ltd.UROV 29,245, acquired Open Form 4 filing 0000903423-19-000232
2019-05-24 P, Open-market purchase Urovant Sciences Ltd.UROV 29,233, acquired Open Form 4 filing 0000903423-19-000232
2019-05-23 P, Open-market purchase Urovant Sciences Ltd.UROV 37,252, acquired Open Form 4 filing 0000903423-19-000229
2019-05-22 P, Open-market purchase Urovant Sciences Ltd.UROV 40,558, acquired Open Form 4 filing 0000903423-19-000229
2019-05-21 P, Open-market purchase Urovant Sciences Ltd.UROV 99,900,025, acquired Open Form 4 filing 0000903423-19-000229
2019-05-20 P, Open-market purchase Urovant Sciences Ltd.UROV 2 lines 80,525, acquired Open Form 4 filing 0000903423-19-000225
2019-05-17 P, Open-market purchase Urovant Sciences Ltd.UROV 45,641, acquired Open Form 4 filing 0000903423-19-000225
2019-05-16 P, Open-market purchase Urovant Sciences Ltd.UROV 36,718, acquired Open Form 4 filing 0000903423-19-000225
2019-03-18 P, Open-market purchase Axovant Sciences Ltd.AXON 10,000,001, acquired Open Form 4 filing 0000903423-19-000151
2018-12-18 P, Open-market purchase Axovant Sciences Ltd.AXON 10,000,000, acquired Open Form 4 filing 0000903423-18-000640
2018-10-01 P, Open-market purchase Urovant Sciences Ltd.UROV 37,499,994, acquired Open Form 4 filing 0000903423-18-000529
2018-06-05 P, Open-market purchase Axovant Sciences Ltd.AXON 25,000,000, acquired Open Form 4 filing 0000903423-18-000324
2018-04-02 P, Open-market purchase Myovant Sciences Ltd.MYOV 22,500,004, acquired Open Form 4 filing 0000903423-18-000192
2015-02-08 P, Open-market purchase Editas Medicine, Inc.EDIT Not reported Open Form 4 filing 0000903423-16-000810
2015-02-08 P, Open-market purchase Editas Medicine, Inc.EDIT Not reported Open Form 4 filing 0000903423-16-000810
2015-02-08 P, Open-market purchase Editas Medicine, Inc.EDIT Not reported Open Form 4 filing 0000903423-16-000810
2015-02-08 P, Open-market purchase Editas Medicine, Inc.EDIT Not reported Open Form 4 filing 0000903423-16-000810
2015-02-08 P, Open-market purchase Editas Medicine, Inc.EDIT Not reported Open Form 4 filing 0000903423-16-000810
2015-02-08 P, Open-market purchase Editas Medicine, Inc.EDIT Not reported Open Form 4 filing 0000903423-16-000810
2015-02-08 P, Open-market purchase Editas Medicine, Inc.EDIT Not reported Open Form 4 filing 0000903423-16-000810
2015-02-08 P, Open-market purchase Editas Medicine, Inc.EDIT Not reported Open Form 4 filing 0000903423-16-000797

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Viking Global Opportunities Portfolio GP LLC, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001629472

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.